SCMP 12.06 Sucampo Pharmaceuticals $SCMP Hit a 52
Post# of 70
Posted On: 11/18/2014 12:22:44 PM
SCMP 12.06 Sucampo Pharmaceuticals $SCMP Hit a 52 week high of 12.06 Closing the day 09:44 at 12.06 +0.47 +4.06% With a day low of 11.60 and a total volume of 36,948.
SCMP Recent Posts: http://investorshangout.com/Sucampo-Pharmaceu...CMP-55384/
SCMP Sucampo Pharmaceuticals Recent Headline News
Sucampo Pharmaceuticals Has Returned 62.8% Since SmarTrend Recommendation (SCMP)
Comtex SmarTrend(R) - Mon Nov 17, 9:25AM CST
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 3 months, Sucampo Pharmaceuticals has returned 62.75% as of today's recent price of $11.36.
SCMP: 11.93 (+0.34)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 4:38PM CST
HK: 2.84 (-0.10), NTES: 101.05 (-0.07), CIG: 4.88 (+0.06), TSRO: 30.92 (+0.93), DDD: 35.72 (+0.39), CLDX: 17.11 (-1.14), SCMP: 11.93 (+0.34), BVN: 9.70 (+0.11), ABGB: 14.46 (+3.11), SSE: 10.38 (-0.76)
Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 46.95 (+0.31), FLML: 13.07 (-0.34), ADHD: 3.17 (-0.28), SCMP: 11.93 (+0.34)
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:11AM CST
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)?
SCMP: 11.93 (+0.34)
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 3:30PM CST
Sucampo Pharmaceuticals, Inc. (SCMP) and partner Takeda Pharmaceutical Company Limited filed a patent infringement lawsuit in the U.S. District Court for the District of New Jersey against Dr. Reddy's Laboratories (RDY).
JAZZ: 171.45 (+1.96), ARQL: 1.24 (unch), SCMP: 11.93 (+0.34), RDY: 56.43 (+0.34)
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:25AM CST
Sucampo Pharmaceuticals (SCMP) was a big mover last session, with shares rising over 7% on the day.
LCI: 46.95 (+0.31), SHPG: 209.02 (+3.03), SCMP: 11.93 (+0.34), CEMP: 13.91 (+0.28)
R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA(R) Capsules Patents
Business Wire - Wed Nov 12, 7:57PM CST
R-Tech Ueno (JASDAQ:4573):
SCMP: 11.93 (+0.34)
Zacks' Bull Of The Day: Sucampo Pharma
Zacks Investment Research - Seeking Alpha - Wed Nov 12, 6:19PM CST
Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP ) recently reported Q3 earnings data which topped both the Zacks Earnings and Revenue estimates. The main driver behind the beats was the strong sales growth of their signature drug Amitiza in both the U.S....
SCMP: 11.93 (+0.34)
Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
GlobeNewswire - Wed Nov 12, 4:31PM CST
Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd., Takeda Pharmaceutical Company Limited (Takeda), and certain affiliates of Takeda have filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, Dr. Reddy's) related to an Abbreviated New Drug Application (ANDA) that Dr. Reddy's filed with the U.S. Food and Drug Administration (FDA) to market, sell and use a generic version of the 8 mcg and 24 mcg AMITIZA (lubiprostone) soft gelatin capsule products. The lawsuit claims infringement of 7 patents that are listed in the FDA's Orange Book, with the latest expiring in 2027.
SCMP: 11.93 (+0.34)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 54.82 (+1.95), SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals, Titan International, Alibaba Group Holding, Costco Wholesale and Tesla Motors highlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Nov 12, 8:30AM CST
Zacks Equity Research highlights Sucampo Pharmaceuticals Inc. (Nasdaq:SCMP-Free Report) as the Bull of the Day and Titan International (NYSE:TWI-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAlibaba Group Holding Limited (NYSE:BABA-Free Report), Costco Wholesale Corp. (Nasdaq:COST-Free Report) and Tesla Motors, Inc. (Nasdaq:TSLA-Free Report).
TSLA: 258.61 (+4.63), SCMP: 11.93 (+0.34), COST: 138.90 (+0.43), TWI: 10.10 (+0.03), BABA: 111.74 (-2.51)
Bull of the Day: Sucampo Pharma (SCMP) - Bull of the Day
Brian Hamilton - ZACKS - Wed Nov 12, 5:30AM CST
Bull of the Day: Sucampo Pharma (SCMP) - Bull of the Day
SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Stifel 2014 Healthcare Conference
GlobeNewswire - Tue Nov 11, 5:45AM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Stifel 2014 Healthcare Conference taking place Tuesday, November 18, 2014 at 4:45 PM ET.
SCMP: 11.93 (+0.34)
Shares of SCMP Up 32.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 4:41PM CST
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 3 months, Sucampo Pharmaceuticals has returned 32.52% as of today's recent price of $9.25.
SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals (SCMP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:25AM CST
SCMP: 11.93 (+0.34)
Sucampo posts 3Q profit
Automated Insights - Thu Nov 06, 5:57AM CST
BETHESDA, Md. (AP) _ Sucampo Pharmaceuticals Inc. (SCMP) on Thursday reported net income of $1.5 million in its third quarter.
SCMP: 11.93 (+0.34)
Sucampo beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:49AM CST
SCMP: 11.93 (+0.34)
Sucampo Announces Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 5:45AM CST
Strong Revenue and Sales Growth for AMITIZA
SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Credit Suisse Global Healthcare Conference
GlobeNewswire - Wed Nov 05, 3:36PM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 2014 Credit Suisse Global Healthcare Conference taking place Wednesday, November 12, 2014 at 3:30 pm Mountain Time, or 5:30 pm Eastern Time.
SCMP: 11.93 (+0.34)
SCMP Recent Posts: http://investorshangout.com/Sucampo-Pharmaceu...CMP-55384/
SCMP Sucampo Pharmaceuticals Recent Headline News
Sucampo Pharmaceuticals Has Returned 62.8% Since SmarTrend Recommendation (SCMP)
Comtex SmarTrend(R) - Mon Nov 17, 9:25AM CST
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 3 months, Sucampo Pharmaceuticals has returned 62.75% as of today's recent price of $11.36.
SCMP: 11.93 (+0.34)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 4:38PM CST
HK: 2.84 (-0.10), NTES: 101.05 (-0.07), CIG: 4.88 (+0.06), TSRO: 30.92 (+0.93), DDD: 35.72 (+0.39), CLDX: 17.11 (-1.14), SCMP: 11.93 (+0.34), BVN: 9.70 (+0.11), ABGB: 14.46 (+3.11), SSE: 10.38 (-0.76)
Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 46.95 (+0.31), FLML: 13.07 (-0.34), ADHD: 3.17 (-0.28), SCMP: 11.93 (+0.34)
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:11AM CST
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)?
SCMP: 11.93 (+0.34)
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 3:30PM CST
Sucampo Pharmaceuticals, Inc. (SCMP) and partner Takeda Pharmaceutical Company Limited filed a patent infringement lawsuit in the U.S. District Court for the District of New Jersey against Dr. Reddy's Laboratories (RDY).
JAZZ: 171.45 (+1.96), ARQL: 1.24 (unch), SCMP: 11.93 (+0.34), RDY: 56.43 (+0.34)
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:25AM CST
Sucampo Pharmaceuticals (SCMP) was a big mover last session, with shares rising over 7% on the day.
LCI: 46.95 (+0.31), SHPG: 209.02 (+3.03), SCMP: 11.93 (+0.34), CEMP: 13.91 (+0.28)
R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA(R) Capsules Patents
Business Wire - Wed Nov 12, 7:57PM CST
R-Tech Ueno (JASDAQ:4573):
SCMP: 11.93 (+0.34)
Zacks' Bull Of The Day: Sucampo Pharma
Zacks Investment Research - Seeking Alpha - Wed Nov 12, 6:19PM CST
Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP ) recently reported Q3 earnings data which topped both the Zacks Earnings and Revenue estimates. The main driver behind the beats was the strong sales growth of their signature drug Amitiza in both the U.S....
SCMP: 11.93 (+0.34)
Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
GlobeNewswire - Wed Nov 12, 4:31PM CST
Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd., Takeda Pharmaceutical Company Limited (Takeda), and certain affiliates of Takeda have filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, Dr. Reddy's) related to an Abbreviated New Drug Application (ANDA) that Dr. Reddy's filed with the U.S. Food and Drug Administration (FDA) to market, sell and use a generic version of the 8 mcg and 24 mcg AMITIZA (lubiprostone) soft gelatin capsule products. The lawsuit claims infringement of 7 patents that are listed in the FDA's Orange Book, with the latest expiring in 2027.
SCMP: 11.93 (+0.34)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 54.82 (+1.95), SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals, Titan International, Alibaba Group Holding, Costco Wholesale and Tesla Motors highlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Nov 12, 8:30AM CST
Zacks Equity Research highlights Sucampo Pharmaceuticals Inc. (Nasdaq:SCMP-Free Report) as the Bull of the Day and Titan International (NYSE:TWI-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAlibaba Group Holding Limited (NYSE:BABA-Free Report), Costco Wholesale Corp. (Nasdaq:COST-Free Report) and Tesla Motors, Inc. (Nasdaq:TSLA-Free Report).
TSLA: 258.61 (+4.63), SCMP: 11.93 (+0.34), COST: 138.90 (+0.43), TWI: 10.10 (+0.03), BABA: 111.74 (-2.51)
Bull of the Day: Sucampo Pharma (SCMP) - Bull of the Day
Brian Hamilton - ZACKS - Wed Nov 12, 5:30AM CST
Bull of the Day: Sucampo Pharma (SCMP) - Bull of the Day
SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Stifel 2014 Healthcare Conference
GlobeNewswire - Tue Nov 11, 5:45AM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Stifel 2014 Healthcare Conference taking place Tuesday, November 18, 2014 at 4:45 PM ET.
SCMP: 11.93 (+0.34)
Shares of SCMP Up 32.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 4:41PM CST
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 3 months, Sucampo Pharmaceuticals has returned 32.52% as of today's recent price of $9.25.
SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals (SCMP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:25AM CST
SCMP: 11.93 (+0.34)
Sucampo posts 3Q profit
Automated Insights - Thu Nov 06, 5:57AM CST
BETHESDA, Md. (AP) _ Sucampo Pharmaceuticals Inc. (SCMP) on Thursday reported net income of $1.5 million in its third quarter.
SCMP: 11.93 (+0.34)
Sucampo beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:49AM CST
SCMP: 11.93 (+0.34)
Sucampo Announces Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 5:45AM CST
Strong Revenue and Sales Growth for AMITIZA
SCMP: 11.93 (+0.34)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Credit Suisse Global Healthcare Conference
GlobeNewswire - Wed Nov 05, 3:36PM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 2014 Credit Suisse Global Healthcare Conference taking place Wednesday, November 12, 2014 at 3:30 pm Mountain Time, or 5:30 pm Eastern Time.
SCMP: 11.93 (+0.34)
(0)
(0)